Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Prevention of Postpartum Depression After Cesarean Section
ChiCTR2600120935Phase 4Recruiting
- Sponsor
- Anyue County Hospital of Traditional Chinese Medicine
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postpartum depression (PPD) (2 arms), sponsored by Anyue County Hospital of Traditional Chinese Medicine. Primary endpoint: Postoperative Edinburgh Postnatal Depression Scale (EPDS) score. Started Mar 2026; status: recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2600120935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120935.